Bradley Glover
Operationeel Directeur bij IMUGENE LIMITED
Vermogen: 109 220 $ op 31-05-2024
Profiel
Bradley Glover is currently the Chief Operating Officer at Imugene Ltd.
He previously worked as the Vice President of Corporate Development at Kite Pharma, Inc. and as the Chief Technology Officer and Executive Vice President at Celularity, Inc. (United States).
He also served as the Chief Operating Officer and Executive Vice President at Celularity, Inc. from 2021 to 2023.
Dr. Glover received his undergraduate degree from the University of California San Diego, his doctorate from the University of Colorado, and his MBA from the Rady School of Management at UC San Diego.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CELULARITY INC. CLASS A
0.16% | 13-04-2023 | 35 119 ( 0.16% ) | 109 220 $ | 31-05-2024 |
Actieve functies van Bradley Glover
| Bedrijven | Functie | Begin |
|---|---|---|
| IMUGENE LIMITED | Operationeel Directeur | 21-08-2023 |
Eerdere bekende functies van Bradley Glover
| Bedrijven | Functie | Einde |
|---|---|---|
| CELULARITY INC. | Operationeel Directeur | 31-05-2023 |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Hoofd Techniek/Wetenschap/O&O | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Opleiding van Bradley Glover
| The University of Colorado | Doctorate Degree |
| Rady School of Management at UC San Diego | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CELULARITY INC. | Commercial Services |
| IMUGENE LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Commercial Services |
